Biomarkers · Vitamins & Endocrine
Free Triiodothyronine (Free T3)
Higher values go with lower risk of death. Not measured in our NHANES panel. The curve is drawn from the published study (source below).
Free T3 and risk of death
Published curve higher than the NHANES fitNHANES fit higher
Risk of death relative to the curve's reference value, drawn from the published study (source below).
Free T3 by age and sex
Each bar runs from the 5th to the 95th percentile, the darker part from the 25th to the 75th, and the tick is the median. Not a reference range or a target.
The percentiles as a table
| Sex | Age | 5th | 25th | Median | 75th | 95th | n | Cycle / source |
|---|---|---|---|---|---|---|---|---|
| All | 20-39 | 2.74 | 3.06 | 3.26 | 3.52 | 3.96 | 570 | NHANES 2011-2012 |
| All | 40-59 | 2.67 | 2.91 | 3.13 | 3.32 | 3.69 | 508 | NHANES 2011-2012 |
| All | 60+ | 2.43 | 2.73 | 2.92 | 3.17 | 3.57 | 512 | NHANES 2011-2012 |
| All | all | 2.58 | 2.90 | 3.13 | 3.36 | 3.80 | 1,590 | NHANES 2011-2012 |
| Men | 20-39 | 2.91 | 3.18 | 3.38 | 3.63 | 4.05 | 295 | NHANES 2011-2012 |
| Men | 40-59 | 2.78 | 3.09 | 3.26 | 3.44 | 3.80 | 252 | NHANES 2011-2012 |
| Men | 60+ | 2.48 | 2.72 | 2.90 | 3.17 | 3.41 | 260 | NHANES 2011-2012 |
| Men | all | 2.66 | 3.01 | 3.23 | 3.45 | 3.90 | 807 | NHANES 2011-2012 |
| Women | 20-39 | 2.66 | 2.99 | 3.16 | 3.38 | 3.82 | 275 | NHANES 2011-2012 |
| Women | 40-59 | 2.64 | 2.80 | 3.00 | 3.18 | 3.62 | 256 | NHANES 2011-2012 |
| Women | 60+ | 2.36 | 2.73 | 2.93 | 3.18 | 3.62 | 252 | NHANES 2011-2012 |
| Women | all | 2.54 | 2.83 | 3.05 | 3.24 | 3.67 | 783 | NHANES 2011-2012 |
What studies found when this marker was changed
They describe what happened in those study groups, not a recommendation. See all catalogued interventions.
Measured changes in Free T3, study by study
1 effect with a numeric size, each from one study arm: the dot is the reported change, the line its 95% interval where one was given. Green points move the marker the way lower risk of death lies; amber the other way. Study results in the groups studied, not predictions for a person.
| Type | Intervention | Reported effect | Evidence | Source |
|---|---|---|---|---|
| diet | Gluten-free diet vs control diet in adults with non-coeliac Hashimoto's thyroiditis (3 RCTs) | Free T3 changed -0.18 pg/mL (95% CI -0.50 to 0.14) with a gluten-free diet vs control; 3 RCTs, n=110; duration not stated | meta-analysis | Araújo EMQ, et al. Nutrients. 2025;17(21):3437. |
Things that worsen it
| Type | Condition or exposure | Reported effect | Evidence | Source |
|---|---|---|---|---|
| pharmacologic | Levothyroxine given once weekly at 7 times the usual daily dose, compared with daily dosing, in hypothyroid adults (randomized crossover) | Trough free T3 208 pg/dL with weekly vs 242 pg/dL with daily dosing (P < 0.01); TSH higher (6.61 vs 3.92 microIU/mL) | RCT | Grebe SK, et al. The Journal of clinical endocrinology and metabolism. 1997… |
What else moves this marker
They describe those study groups, not an individual, and an association is not a cause.
Diseases and conditions
| What | Effect on the marker | Comparison · population | Source |
|---|---|---|---|
| ↓ Iron deficiency · patients with iron deficiency vs healthy controls without iron deficiency | -0.143 pg/mL (95% CI -0.208 to -0.078) | iron deficiency vs no iron deficiency · 10 cross-sectional studies; pregnant and non-pregnant women subgroups | meta analysis · PMID 38004184 |
Genetic predisposition
| What | Effect on the marker | Comparison · population | Source |
|---|---|---|---|
| ↕ Genome-wide significant loci for free T3 (ThyroidOmics) · total variation in free T3 concentration explained by associated loci | +1.1% | variance explained · European-ancestry adults with reference-range thyroid function | gwas · PMID 38291025 |
Sources
- Risk curve: Lang X 2022 (PMID 36060933): all-cause HR 0.81 (0.7-0.93) per SD higher free triiodothyronine (FT3). Scaled to US values (NHANES).
- Lang X, Li Y, Zhang D, Zhang Y, Wu N, Zhang Y. FT3/FT4 ratio is correlated with all-cause mortality, cardiovascular mortality, and cardiovascular disease risk: NHANES 2007-2012. Frontiers in Endocrinology. 2022;13:964822.
Map Free Triiodothyronine (Free T3) against another biomarker.
Related markers: Adiponectin · C-peptide · Dehydroepiandrosterone Sulfate (DHEA-S) · Estradiol-to-SHBG Ratio · Insulin-like Growth Factor 1 (IGF-1) · Serum 25-Hydroxyvitamin D · Serum Cortisol · Serum Folate